Immunomodulatory function of the 5-HT3 receptor antagonist tropisetron

Scand J Rheumatol Suppl. 2004:119:34-40.

Abstract

Objective: To characterize the immune modulatory effects of 5-HT3 receptor antagonist treatment in patients with fibromyalgia, autoimmune disorders, and chronic pain.

Methods: Multiplex-assisted cytokine measurements were performed before and during treatment. Whole blood stimulation with TNF-alpha was carried out to determine the proinflammatory response induced by exogenous TNF-alpha.

Results: Five of nine patients clinically responded to treatment, and two had a moderate response. All patients had significantly elevated levels of T-H1 cytokines more prominent than TNF-alpha, IL-1beta, and IL-6. Treatment resulted in transient effects on peripheral monocyte counts in all but one patient, a plasma IL-1beta increase in two responder patients, and decreased T-H1 cytokines in two responder patients. Ex vivo TNF-alpha stimulation was transiently reconstituted in three responder patients to a significant level. Three patients showed a marginal reconstitutive response.

Conclusion: 5-HT3 receptor blockade transiently affects monocyte tissue infiltration, modulates T-H1 cytokines in clinical responders as well as MIP-1beta in moderate responders, and transiently affects the ex vivo response to exogenous TNF-alpha.

MeSH terms

  • Adult
  • Aged
  • Autoimmune Diseases / complications
  • Autoimmune Diseases / drug therapy
  • Chronic Disease
  • Fibromyalgia / complications
  • Fibromyalgia / drug therapy
  • Humans
  • Immune System / drug effects
  • Indoles / therapeutic use*
  • Middle Aged
  • Pain / drug therapy*
  • Pain / etiology
  • Serotonin 5-HT3 Receptor Antagonists*
  • Serotonin Antagonists / therapeutic use*
  • Tropisetron

Substances

  • Indoles
  • Serotonin 5-HT3 Receptor Antagonists
  • Serotonin Antagonists
  • Tropisetron